Boehringer Ingelheim Pharmaceuticals, Inc.
2 FDA actions
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per B
Boehringer Ingelheim Pharmaceuticals, Inc.
drugClass II
JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) b
Boehringer Ingelheim Pharmaceuticals, Inc.
drugClass II